Algeria vs Lao People's Democratic Republic: Protecting minority investors (DB15-20 methodology) - Score
Algeria
20
in 2019
Lao People's Democratic Republic
20
in 2019
Algeria rank
179th
Lao People's Democratic Republic rank
179th
Protecting minority investors (DB15-20 methodology) - Score over time
- Algeria
- Lao People's Democratic Republic
How they compare
Algeria currently reports 20 against 20 in Lao People's Democratic Republic, a difference of 0.
The two have swapped places 1 time across 7 shared years of data; in 2013 it was Algeria ahead.
Algeria ranks 179th and Lao People's Democratic Republic ranks 179th of 190 countries.
Algeria has averaged higher in every one of the 1 decades both report.
Frequently asked questions
- Which has higher protecting minority investors (db15-20 methodology) - score, Algeria or Lao People's Democratic Republic?
- Algeria, at 20 against 20 in Lao People's Democratic Republic as of 2019.
- What is the difference in protecting minority investors (db15-20 methodology) - score between Algeria and Lao People's Democratic Republic?
- 0, with Algeria ahead.
- How many years of comparable data are there for Algeria and Lao People's Democratic Republic?
- 7 years are reported by both, from 2013 to 2019.
- How do Algeria and Lao People's Democratic Republic rank globally for protecting minority investors (db15-20 methodology) - score?
- Algeria ranks 179th and Lao People's Democratic Republic ranks 179th of 190 countries.
- Where does this data come from?
- The World Bank, published as Protecting minority investors (DB15-20 methodology) - Score. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The score for protecting minority investors benchmarks economies with respect to the regulatory best practice on the indicator set. The score is indicated on a scale from 0 to 100, where 0 represents the worst regulatory performance and 100 the best regulatory performance, and is computed based on the methodology in the DB15-20 studies.